Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Mark E. Strome10% Owner | Zivo BioscienceZIVO | Open-market buy | 04/17 | 04/24 | 100,000 sh | $2.00 | $200,000 | +21.1% |
Zivo BioscienceZIVO | Open-market buy | 04/17 | 04/24 | 100,000 sh | $2.00 | $200,000 | +21.1% | |
Strome GroupOther | Zivo BioscienceZIVO | Open-market buy | 04/17 | 04/24 | 100,000 sh | $2.00 | $200,000 | +21.1% |
Laith L. YaldooDirector | Zivo BioscienceZIVO | Open-market buy | 02/27 | 03/03 | 1,543 sh | $9.72 | $14,997.96 | +0.3% |
Mark E. Strome10% Owner | Zivo BioscienceZIVO | Open-market buy | 02/12 | 02/17 | 20,000 sh | $9.77 | $195,400 | +4.4% |
Zivo BioscienceZIVO | Open-market buy | 02/12 | 02/17 | 20,000 sh | $9.77 | $195,400 | +4.4% | |
Strome GroupOther | Zivo BioscienceZIVO | Open-market buy | 02/12 | 02/17 | 20,000 sh | $9.77 | $195,400 | +4.4% |
Laith L. YaldooDirector | Zivo BioscienceZIVO | Open-market buy | 02/10 | 02/12 | 2,434 sh | $10.27 | $24,997.18 | +0.4% |
Alison A. CornellDirector | Zivo BioscienceZIVO | Open-market buy | 01/26 | 01/28 | 11,709 sh | $8.54 | $99,994.86 | +4.4% |
John Bernard PaynePresident and CEO | Zivo BioscienceZIVO | Open-market buy | 01/26 | 01/28 | 11,709 sh | $8.54 | $99,994.86 | +148.0% |
Christopher D. MaggioreDirector | Zivo BioscienceZIVO | Open-market buy | 01/14 | 01/27 | 1,766 sh | $8.49 | $14,993.34 | +0.3% |
Laith L. YaldooDirector | Zivo BioscienceZIVO | Open-market buy | 01/14 | 01/27 | 1,766 sh | $8.49 | $14,993.34 | +0.3% |
Laith L. YaldooDirector | Zivo BioscienceZIVO | Open-market buy | 25/11/28 | 25/12/02 | 2,777 sh | $9.00 | $24,993 | +0.5% |
Mark E. Strome10% Owner | Zivo BioscienceZIVO | Open-market buy | 25/10/13 | 25/10/20 | 20,259 sh | $12.34 | $249,996.06 | +4.7% |
Zivo BioscienceZIVO | Open-market buy | 25/10/13 | 25/10/20 | 20,259 sh | $12.34 | $249,996.06 | +4.7% | |
Strome GroupOther | Zivo BioscienceZIVO | Open-market buy | 25/10/13 | 25/10/20 | 20,259 sh | $12.34 | $249,996.06 | +4.7% |
Laith L. YaldooDirector | Zivo BioscienceZIVO | Open-market buy | 25/10/10 | 25/10/14 | 1,659 sh | $12.05 | $19,990.95 | +0.3% |
Christopher D. MaggioreDirector | Zivo BioscienceZIVO | Open-market buy | 25/10/08 | 25/10/09 | 23,682 sh | $12.01 | $284,420.82 | +4.8% |
Laith L. YaldooDirector | Zivo BioscienceZIVO | Open-market buy | 25/09/30 | 25/10/02 | 15,322 sh | $15.99 | $244,998.78 | +2.7% |
Laith L. YaldooDirector | Zivo BioscienceZIVO | Open-market buy | 25/06/13 | 25/06/16 | 3,488 sh | $14.33 | $49,983.04 | +0.6% |